Nguyen Tuan V
Bone Biology Division, Garvan Institute of Medical Research, Sydney, Australia.
St Vincent's Clinical School, UNSW Sydney, Australia.
Osteoporos Sarcopenia. 2018 Mar;4(1):2-10. doi: 10.1016/j.afos.2018.03.001. Epub 2018 Mar 22.
Fragility fracture is a serious clinical event, because it is associated with increased risk of mortality and reduced quality of life. The risk of fracture is determined by multiple risk factors, and their effects may be interactional. Over the past 10 years, a number of predictive models (e.g., FRAX, Garvan Fracture Risk Calculator, and Qfracture) have been developed for individualized assessment of fracture risk. These models use different risk profiles to estimate the probability of fracture over 5- and 10-year period. The ability of these models to discriminate between those individuals who will and will not have a fracture (i.e., area under the receiver operating characteristic curve [AUC]) is generally acceptable-to-good (AUC, 0.6 to 0.8), and is highly variable between populations. The calibration of existing models is poor, particularly in Asian populations. There is a strong need for the development and validation of new prediction models based on Asian data for Asian populations. We propose approaches to improve the accuracy of existing predictive models by incorporating new markers such as genetic factors, bone turnover markers, trabecular bone score, and time-variant factors. New and more refined models for individualized fracture risk assessment will help identify those most likely to sustain a fracture, those most likely to benefit from treatment, and encouraging them to modify their risk profile to decrease risk.
脆性骨折是一种严重的临床事件,因为它与死亡率增加和生活质量下降相关。骨折风险由多种风险因素决定,且这些因素的作用可能相互影响。在过去10年里,已经开发了一些预测模型(如FRAX、加尔万骨折风险计算器和Qfracture)用于骨折风险的个体化评估。这些模型使用不同的风险概况来估计5年和10年内骨折的概率。这些模型区分会发生骨折和不会发生骨折个体的能力(即受试者工作特征曲线下面积[AUC])总体上是可接受至良好的(AUC为0.6至0.8),且在不同人群之间差异很大。现有模型的校准效果不佳,尤其是在亚洲人群中。迫切需要基于亚洲数据为亚洲人群开发和验证新的预测模型。我们提出通过纳入遗传因素、骨转换标志物、小梁骨评分和时变因素等新标志物来提高现有预测模型准确性的方法。新的、更精细的个体化骨折风险评估模型将有助于识别最有可能发生骨折的人群、最有可能从治疗中获益的人群,并鼓励他们改变风险概况以降低风险。